President Donald J. Trump announced on April 2 that the United States will impose tariffs on patented pharmaceutical products in an effort to bolster national security and reinforce domestic supply chains.
The decision aims to ensure that the country is able to manufacture its own pharmaceutical products, which officials say is important for safety, security, and public health.
According to the announcement, this action builds upon previous commitments by President Trump to prioritize American interests. The administration said it seeks to protect national security and support American manufacturing across all sectors.
No further details about the scope of the tariffs or their expected impact were provided in the statement.
